03:54:51 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-09-10 Årsstämma 2025
2024-06-05 Bokslutskommuniké 2024
2024-03-08 Kvartalsrapport 2024-Q3
2023-12-15 Kvartalsrapport 2024-Q2
2023-10-09 Inlösen SECT B 1.1
2023-09-08 Ordinarie utdelning SECT B 0.00 SEK
2023-09-07 Årsstämma 2024
2023-09-05 Kvartalsrapport 2024-Q1
2023-06-02 Bokslutskommuniké 2023
2023-03-10 Kvartalsrapport 2023-Q3
2022-12-16 Kvartalsrapport 2023-Q2
2022-10-10 Inlösen SECT B 1
2022-09-09 Ordinarie utdelning SECT B 0.00 SEK
2022-09-08 Årsstämma 2023
2022-09-02 Kvartalsrapport 2023-Q1
2022-06-03 Bokslutskommuniké 2022
2022-03-09 Kvartalsrapport 2022-Q3
2021-12-10 Kvartalsrapport 2022-Q2
2021-10-18 Inlösen SECT B 0.9
2021-09-24 Split SECT B 1:5
2021-09-15 Ordinarie utdelning SECT B 0.00 SEK
2021-09-14 Årsstämma 2022
2021-09-03 Kvartalsrapport 2022-Q1
2021-06-02 Bokslutskommuniké 2021
2021-03-12 Kvartalsrapport 2021-Q3
2020-11-27 Kvartalsrapport 2021-Q2
2020-10-05 Inlösen SECT B 4.5
2020-09-09 Ordinarie utdelning SECT B 0.00 SEK
2020-09-08 Årsstämma 2021
2020-09-04 Kvartalsrapport 2021-Q1
2020-06-03 Bokslutskommuniké 2020
2020-03-04 Kvartalsrapport 2020-Q3
2019-11-28 Kvartalsrapport 2020-Q2
2019-10-02 Inlösen SECT B 4.5
2019-09-06 Ordinarie utdelning SECT B 0.00 SEK
2019-09-05 Årsstämma 2020
2019-09-03 Kvartalsrapport 2020-Q1
2019-05-28 Bokslutskommuniké 2019
2019-03-06 Kvartalsrapport 2019-Q3
2018-12-07 Kvartalsrapport 2019-Q2
2018-10-03 Inlösen SECT B 4.5
2018-09-07 Ordinarie utdelning SECT B 0.00 SEK
2018-09-06 Årsstämma 2019
2018-09-04 Kvartalsrapport 2019-Q1
2018-05-29 Bokslutskommuniké 2018
2018-03-12 Kvartalsrapport 2018-Q3
2017-12-08 Kvartalsrapport 2018-Q2
2017-10-02 Inlösen SECT B 4.5
2017-09-14 Ordinarie utdelning SECT B 0.00 SEK
2017-09-13 Årsstämma 2018
2017-09-12 Kvartalsrapport 2018-Q1
2017-05-30 Bokslutskommuniké 2017
2017-03-07 Kvartalsrapport 2017-Q3
2016-12-07 Kvartalsrapport 2017-Q2
2016-10-04 Inlösen SECT B 4.5
2016-09-07 Ordinarie utdelning SECT B 0.00 SEK
2016-09-06 Årsstämma 2017
2016-09-05 Kvartalsrapport 2017-Q1
2016-05-31 Bokslutskommuniké 2016
2016-03-08 Kvartalsrapport 2016-Q3
2015-12-08 Kvartalsrapport 2016-Q2
2015-09-28 Inlösen SECT B 4.5
2015-09-15 Kapitalmarknadsdag 2015
2015-09-08 Ordinarie utdelning SECT B 0.00 SEK
2015-09-07 Årsstämma 2016
2015-09-07 Kvartalsrapport 2016-Q1
2015-06-03 Bokslutskommuniké 2015
2015-03-10 Kvartalsrapport 2015-Q3
2014-12-09 Kvartalsrapport 2015-Q2
2014-09-25 Inlösen SECT B 4.5
2014-09-09 Ordinarie utdelning SECT B 0.00 SEK
2014-09-08 Årsstämma 2015
2014-09-08 Kvartalsrapport 2015-Q1
2014-05-27 Bokslutskommuniké 2014
2014-03-04 Kvartalsrapport 2014-Q3
2013-12-10 Kvartalsrapport 2014-Q2
2013-09-10 Kvartalsrapport 2014-Q1
2013-07-11 Inlösen SECT B 4.5
2013-06-28 Ordinarie utdelning SECT B 0.00 SEK
2013-06-27 Årsstämma 2013
2013-05-29 Bokslutskommuniké 2013
2013-05-28 Bokslutskommuniké 2012
2013-05-28 Analytiker möte 2013
2013-03-06 Kapitalmarknadsdag 2013
2013-03-05 Kvartalsrapport 2012-Q3
2012-12-04 Kvartalsrapport 2012-Q2
2012-09-04 Kvartalsrapport 2012-Q1
2012-07-12 Inlösen SECT B 5
2012-06-29 Ordinarie utdelning SECT B 0.00 SEK
2012-06-28 Årsstämma 2011
2012-05-22 Analytiker möte 2011
2012-05-21 Bokslutskommuniké 2011
2012-03-05 Kvartalsrapport 2011-Q3
2011-12-06 15-7 2011
2011-12-05 Inlösen SECT B 5
2011-12-04 Kvartalsrapport 2011-Q2
2011-11-23 Ordinarie utdelning SECT B 0.00 SEK
2011-11-22 Extra Bolagsstämma 2011
2011-09-04 Kvartalsrapport 2011-Q1
2011-05-24 Bokslutskommuniké 2010
2011-03-08 Kvartalsrapport 2010-Q3
2010-07-01 Ordinarie utdelning SECT B 0.00 SEK
2010-06-30 Årsstämma 2010
2010-05-25 Bokslutskommuniké 2009
2010-03-16 Kvartalsrapport 2009-Q3
2009-12-08 Kvartalsrapport 2009-Q2
2009-09-14 Kvartalsrapport 2009-Q1
2009-06-29 Ordinarie utdelning SECT B 0.00 SEK
2009-06-26 Årsstämma 1
2008-06-26 Ordinarie utdelning SECT B 0.50 SEK
2007-06-29 Ordinarie utdelning SECT B 0.50 SEK
2006-06-29 Ordinarie utdelning SECT B 0.50 SEK
2000-08-11 Split SECT B 1:3

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Sectra är verksamt inom säkerhetslösningar. Störst affärsinriktning återfinns inom medicinteknik och cybersäkerhet. Bolaget utvecklar IT-lösningar som används bland sjukhus, institut och myndigheter på global nivå för hantering av kritisk infrastruktur samt känslig datainformation. Störst verksamhet återfinns inom den europeiska marknaden, där lösningarna säljs via flertalet dotterbolag. Sectra grundades 1978 och har sitt huvudkontor i Linköping.
2022-03-17 08:31:00

Linköping, Sweden - March 17, 2022 - International medical imaging IT and cybersecurity company Sectra (https://sectra.com/) (STO: SECT B) has signed a digital pathology contract with Erasmus University Medical Center (Erasmus MC) in the Netherlands. The solution will enable pathologists to review and collaborate around cases in a way that is not possible with microscopes. This will reduce variation and increase efficiency in primary diagnostics, thereby improving cancer care.

"With Sectra's digital pathology solution, we are able to integrate it with our vendor-neutral archive (VNA). That makes it possible for us to access images from various diagnostic areas, which will provide us with an integrated workflow across departments. It means that we can cooperate better and ultimately provide even better patient care," says Prof. Dr. F.J (Folkert) van Kemenade, Head of Pathology at Erasmus MC. 

Using digital images of tissue samples instead of physical glass slides, Sectra's solution allows pathologists to instantly access and share current and historical images and information between departments and hospitals and to benefit from evolving technology such as AI. The digital solution provides pathologists with assistance at critical decision points, such as grading or performing more precise measurements. It also enables image analysis, which in turn reduces variation and improves the precision of tasks such as cell counting. Digital access further facilitates second opinions and external reading resources as well as enabling integrated diagnostics.

"Sectra's previous experience of digitalization projects for full-scale primary diagnostics within pathology, both in the Netherlands and globally, will be a great asset and we look forward to taking this step together to improve cancer care," says Prof. Dr. van Kemenade. 

Sectra's solution will be integrated with surrounding IT solutions such as the laboratory information system (LIS) used at Erasmus MC. It will provide pathologists with a complete overview of the patient history in one application and enable workflow orchestration to drive the reporting workflow according to sub-specialties, rules, and priorities. The solution's vendor-neutral approach also gave Erasmus MC the freedom to select the scanner vendor of their choice. 

The contract was signed in March 2022.

Sectra's pathology solution is part of its enterprise imaging solution, which provides a unified strategy for all imaging needs while lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise. Visit Sectra's website to read more about Sectra and why it's top-ranked in "Best in KLAS (https://medical.sectra.com/about-sectra/sectra-pacs-best-in-klas/)".

About Sectra
Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2020/2021 fiscal year totaled SEK 1,632 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website (https://sectra.com/).